Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Gerard T Vondeling"'
Autor:
Kris Rama, Adrianne M de Roo, Timon Louwsma, Hinko S Hofstra, Gabriel S Gurgel do Amaral, Gerard T Vondeling, Maarten J Postma, Roel D Freriks
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 18, Iss 6, p e0012254 (2024)
BackgroundChikungunya is a viral disease caused by a mosquito-borne alphavirus. The acute phase of the disease includes symptoms such as fever and arthralgia and lasts 7-10 days. However, debilitating symptoms can persist for months or years. Despite
Externí odkaz:
https://doaj.org/article/9b7c47ac435d414ba803f600e085a90c
Autor:
Giorgia Tiozzo, Timon Louwsma, Stefan R A Konings, Gerard T Vondeling, Judith Perez Gomez, Maarten J Postma, Roel D Freriks
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 410-418 (2023)
Background Evidence-based reassurances addressing vaccine-related concerns are crucial to promoting primary vaccination, completion of the primary series, and booster vaccination. By summarizing and comparing the reactogenicity of COVID-19 vaccines a
Externí odkaz:
https://doaj.org/article/e584a798b2c6448f8879a90f39106932
Autor:
Emily I. Holthuis, Gerard T. Vondeling, Josephina G. Kuiper, Vincent Dezentjé, Mats Rosenlund, Jetty A. Overbeek, Carolien H.M. van Deurzen
Publikováno v:
Breast, Vol 66, Iss , Pp 278-284 (2022)
Background: With the introduction of investigational human epidermal growth factor receptor 2 (HER2) targeting treatments, thorough understanding of breast cancer with different HER2 expression levels is critical. The aim of this study was to compare
Externí odkaz:
https://doaj.org/article/f27723d95f8e4f1087383b9359ad986c
Autor:
Ashley Jaksa, Anthony Louder, Christina Maksymiuk, Gerard T. Vondeling, Laura Martin, Nicolle Gatto, Eric Richards, Antoine Yver, Mats Rosenlund
Publikováno v:
Value in Health. 25:1967-1976
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6e0d63415b0ca57d7080a1d01bf1b8b
https://doi.org/10.1016/j.jval.2022.05.016
https://doi.org/10.1016/j.jval.2022.05.016
Autor:
Carol Mansfield, Willings Botha, Gerard T. Vondeling, Kathleen Klein, Kongming Wang, Jasmeet Singh, Michelle D. Hackshaw
Publikováno v:
Breast cancer (Tokyo, Japan). 30(1)
Background We aimed to quantify patients’ benefit-risk preferences for attributes associated with human epidermal growth factor receptor 2 (HER2)-targeted breast cancer treatments and estimate minimum acceptable benefits (MABs), denominated in addi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5e1dd085626392c75c9d3ba8b020df2
https://pubmed.ncbi.nlm.nih.gov/36074320
https://pubmed.ncbi.nlm.nih.gov/36074320
Autor:
Ashley, Jaksa, Anthony, Louder, Christina, Maksymiuk, Gerard T, Vondeling, Laura, Martin, Nicolle, Gatto, Eric, Richards, Antoine, Yver, Mats, Rosenlund
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 25(12)
The development of accelerated approval programs for high morbidity and unmet need conditions has driven the use of single-arm studies in drug development. Regulatory and health technology assessment (HTA) agencies are recognizing that high-quality e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::54e87ca286fcf590b5ffe6747c46d23d
https://pubmed.ncbi.nlm.nih.gov/35760714
https://pubmed.ncbi.nlm.nih.gov/35760714
Publikováno v:
Universidad de Lima
Repositorio Institucional-Ulima
Applied Health Economics and Health Policy
Repositorio Institucional-Ulima
Applied Health Economics and Health Policy
Carta al editor: Vondeling et al. Recientemente han publicado en Applied Health Economics and Health Policy (AHEHP) una revisión sistemática (SR) sobre el impacto de la caducidad de la patente en los precios de los medicamentos (original y genéric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::530d2194b6f7ba2b97c5f07ea853ffde
https://doi.org/10.1007/s40258-018-0406-6
https://doi.org/10.1007/s40258-018-0406-6
Autor:
Lee Bennett, Kaku Saito, Kohei Shitara, Yung-Jue Bang, Gerard T. Vondeling, Michelle D Hackshaw, Diana Garbinsky, Masahiro Sugihara, David Cella, Kensei Yamaguchi
Publikováno v:
Journal of Clinical Oncology. 39:4057-4057
4057 Background: DESTINY-Gastric01 (NCT03329690) is a randomized, phase 2 study evaluating trastuzumab deruxtecan (T-DXd) in patients with HER2-positive advanced gastric cancer who progressed after ≥2 regimens. T-DXd significantly improved objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7190aa0edd3e0a4c2bd027fd04c7d9cb
https://doi.org/10.1200/jco.2021.39.15_suppl.4057
https://doi.org/10.1200/jco.2021.39.15_suppl.4057